Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Point of Care Infectious Disease Testing Market by Type (HIV POC, HBV POC, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus (RSV) POC, HPV POC, Influenza POC, Others), By Application (Hospitals, Clinics, Home, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Point of Care Infectious Disease Testing Market by Type (HIV POC, HBV POC, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus (RSV) POC, HPV POC, Influenza POC, Others), By Application (Hospitals, Clinics, Home, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 263668 4200 Medical Devices & Consumables 377 145 Pages 4.6 (41)
                                          

Market Overview:


The global point of care infectious disease testing market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, growing demand for rapid diagnosis, and technological advancements in point-of-care diagnostics. Based on type, the global point of care infectious disease testing market is segmented into HIV POC, HBV POC, pneumonia or streptococcus associated infections POC, respiratory syncytial virus (RSV) POC HPV POC and influenza POC. The HIVPoc segment is expected to account for the largest share of the global pointof care infectious disease testing market in 2018. This can be attributed tothe high prevalence of HIV infection across the globe and growing demand for rapid diagnosis thereof.


Global Point of Care Infectious Disease Testing Industry Outlook


Product Definition:


Point of care infectious disease testing is a type of diagnostic test that can be performed quickly and easily in a doctor's office or other healthcare setting. These tests are used to diagnose infections and determine the best course of treatment. Point of care tests can provide results in minutes, which allows doctors to make decisions quickly about how to treat patients.


HIV POC:


HIV POC, also known as rapid testing for HIV, is a self-administered test used to detect the Human Immunodeficiency Virus (HIV) in patients who are experiencing symptoms of HIV infection. The test works by detecting antibodies made by the immune system in response to HIV. Currently, there are 2 FDA-approved rapid tests that can be used at home; OraQuick In-Home Test and TruSight Home Collection Kit.


HBV POC:


The HBV POC and it’s usage in Point of Care (POC) infectious disease testing market is expected to witness lucrative growth over the forecast period owing to increasing prevalence of hepatitis B virus globally. Hepatitis is a liver infection which can result into several complications such as chronic inflammation, fibrosis or cirrhosis, and eventually death. The major symptoms associated with this viral infection are jaundice, abdominal pain, loss of appetite, nausea & vomiting.


Application Insights:


The market is segmented based on the application as hospitals, clinics, home and others. The hospitals segment dominated the global point of care infectious disease testing market in 2017 due to factors such as increasing hospital admissions for a variety of chronic diseases that are associated with an increased risk of developing infections. According to WHO, around 50 million people die from chronic diseases every year globally which accounts for about 15% of all deaths worldwide. This fact has led to an increase in demand for highly efficient diagnostic tools that help detect infectious diseases at their early stages so that appropriate treatment can be administered before they cause severe damage or death.


Point-of-care tests have helped reduce mortality rates among patients suffering from life-threatening conditions by enabling accurate diagnosis at the time when it matters most and thus contributing towards sustainable growth during this period of high prevalence and incidence rate coupled with growing investments by governments across various regions into strengthening healthcare infrastructure has resulted in steady growth over recent years.


Regional Analysis:


North America dominated the global point of care infectious disease testing market in 2016. This can be attributed to the presence of a large number of players, increasing investments in R&D, and high prevalence rate for various infectious diseases. The Asia Pacific is expected to grow at a lucrative CAGR over the forecast period owing to improving healthcare infrastructure and growing awareness about early diagnosis. Moreover, an increase in government initiatives such as “One Test To Rule Them All” is also anticipated to drive regional growth during the forecast period.


Major participants operating in this space include Bio-Rad Laboratories Inc.; Chugai Pharmaceutical Co., Ltd.; Fujifilm Wako Pure Chemical Corp.; Hygiena LLC; Roche Molecular Systems GmbH; Siemens Healthcare Diagnostics USA LLC; and UBS Health Products (UBS).


Growth Factors:


  • Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the key growth drivers for the point-of-care infectious disease testing market. This is because the demand for rapid and accurate diagnosis and treatment of these infections has been on the rise in recent years.
  • Technological advancements: The advent of novel technologies such as next-generation sequencing (NGS) has revolutionized the field of diagnostics, and this is expected to drive demand for point-of-care infectious disease tests in the coming years.
  • Growing awareness about benefits offered by POC tests: There is a growing awareness among healthcare professionals about the benefits offered by POC tests, such as their ability to provide rapid results with high accuracy levels. This is likely to boost demand for these tests in the coming years.
  • Rising number of outbreaks due to antibiotic resistance: The increasing number of outbreaks caused by antibiotic resistance is another major factor that is expected to fuel growth in demand for point-of-care infectious disease testing over the forecast period. This is because timely diagnosis and treatment are essential to preventing such outbreaks from spreading further and causing more damage . 5

Scope Of The Report

Report Attributes

Report Details

Report Title

Point of Care Infectious Disease Testing Market Research Report

By Type

HIV POC, HBV POC, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus (RSV) POC, HPV POC, Influenza POC, Others

By Application

Hospitals, Clinics, Home, Others

By Companies

Alere, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens Healthineers, BD, Chembio Diagnostics, Trinity Biotech, Cardinal Health, Quest Diagnostics, Bio-Rad Labs, bioMérieux, Sight Diagnostics, Gene POC, Trivitron Healthcare, OJ-Bio, Ortho-Clinical Diagnostics

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

145

Number of Tables & Figures

102

Customization Available

Yes, the report can be customized as per your need.


Global Point of Care Infectious Disease Testing Market Report Segments:

The global Point of Care Infectious Disease Testing market is segmented on the basis of:

Types

HIV POC, HBV POC, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus (RSV) POC, HPV POC, Influenza POC, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals, Clinics, Home, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Alere
  2. Thermo Fisher Scientific
  3. F. Hoffmann-La Roche
  4. Siemens Healthineers
  5. BD
  6. Chembio Diagnostics
  7. Trinity Biotech
  8. Cardinal Health
  9. Quest Diagnostics
  10. Bio-Rad Labs
  11. bioMérieux
  12. Sight Diagnostics
  13. Gene POC
  14. Trivitron Healthcare
  15. OJ-Bio
  16. Ortho-Clinical Diagnostics

Global Point of Care Infectious Disease Testing Market Overview


Highlights of The Point of Care Infectious Disease Testing Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. HIV POC
    2. HBV POC
    3. Pneumonia or Streptococcus Associated Infections
    4. Respiratory Syncytial Virus (RSV) POC
    5. HPV POC
    6. Influenza POC
    7. Others
  1. By Application:

    1. Hospitals
    2. Clinics
    3. Home
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Point of Care Infectious Disease Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Point of Care Infectious Disease Testing Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Point of care infectious disease testing is a type of laboratory test that can be performed on a patient without having to go to the hospital. This type of test is used to diagnose or monitor infections in patients who are not able to go to the hospital.

Some of the major companies in the point of care infectious disease testing market are Alere, Thermo Fisher Scientific, F. Hoffmann-La Roche, Siemens Healthineers, BD, Chembio Diagnostics, Trinity Biotech, Cardinal Health, Quest Diagnostics, Bio-Rad Labs, bioM©rieux, Sight Diagnostics, Gene POC, Trivitron Healthcare, OJ-Bio, Ortho-Clinical Diagnostics.

The point of care infectious disease testing market is expected to register a CAGR of 7.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Point of Care Infectious Disease Testing Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Point of Care Infectious Disease Testing Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Point of Care Infectious Disease Testing Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Point of Care Infectious Disease Testing Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Point of Care Infectious Disease Testing Market Size & Forecast, 2018-2028       4.5.1 Point of Care Infectious Disease Testing Market Size and Y-o-Y Growth       4.5.2 Point of Care Infectious Disease Testing Market Absolute $ Opportunity

Chapter 5 Global Point of Care Infectious Disease Testing Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Point of Care Infectious Disease Testing Market Size Forecast by Type
      5.2.1 HIV POC
      5.2.2 HBV POC
      5.2.3 Pneumonia or Streptococcus Associated Infections
      5.2.4 Respiratory Syncytial Virus (RSV) POC
      5.2.5 HPV POC
      5.2.6 Influenza POC
      5.2.7 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Point of Care Infectious Disease Testing Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Point of Care Infectious Disease Testing Market Size Forecast by Applications
      6.2.1 Hospitals
      6.2.2 Clinics
      6.2.3 Home
      6.2.4 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Point of Care Infectious Disease Testing Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Point of Care Infectious Disease Testing Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Point of Care Infectious Disease Testing Analysis and Forecast
   9.1 Introduction
   9.2 North America Point of Care Infectious Disease Testing Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Point of Care Infectious Disease Testing Market Size Forecast by Type
      9.6.1 HIV POC
      9.6.2 HBV POC
      9.6.3 Pneumonia or Streptococcus Associated Infections
      9.6.4 Respiratory Syncytial Virus (RSV) POC
      9.6.5 HPV POC
      9.6.6 Influenza POC
      9.6.7 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Point of Care Infectious Disease Testing Market Size Forecast by Applications
      9.10.1 Hospitals
      9.10.2 Clinics
      9.10.3 Home
      9.10.4 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Point of Care Infectious Disease Testing Analysis and Forecast
   10.1 Introduction
   10.2 Europe Point of Care Infectious Disease Testing Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Point of Care Infectious Disease Testing Market Size Forecast by Type
      10.6.1 HIV POC
      10.6.2 HBV POC
      10.6.3 Pneumonia or Streptococcus Associated Infections
      10.6.4 Respiratory Syncytial Virus (RSV) POC
      10.6.5 HPV POC
      10.6.6 Influenza POC
      10.6.7 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Point of Care Infectious Disease Testing Market Size Forecast by Applications
      10.10.1 Hospitals
      10.10.2 Clinics
      10.10.3 Home
      10.10.4 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Point of Care Infectious Disease Testing Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Point of Care Infectious Disease Testing Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Point of Care Infectious Disease Testing Market Size Forecast by Type
      11.6.1 HIV POC
      11.6.2 HBV POC
      11.6.3 Pneumonia or Streptococcus Associated Infections
      11.6.4 Respiratory Syncytial Virus (RSV) POC
      11.6.5 HPV POC
      11.6.6 Influenza POC
      11.6.7 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Point of Care Infectious Disease Testing Market Size Forecast by Applications
      11.10.1 Hospitals
      11.10.2 Clinics
      11.10.3 Home
      11.10.4 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Point of Care Infectious Disease Testing Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Point of Care Infectious Disease Testing Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Point of Care Infectious Disease Testing Market Size Forecast by Type
      12.6.1 HIV POC
      12.6.2 HBV POC
      12.6.3 Pneumonia or Streptococcus Associated Infections
      12.6.4 Respiratory Syncytial Virus (RSV) POC
      12.6.5 HPV POC
      12.6.6 Influenza POC
      12.6.7 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Point of Care Infectious Disease Testing Market Size Forecast by Applications
      12.10.1 Hospitals
      12.10.2 Clinics
      12.10.3 Home
      12.10.4 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Point of Care Infectious Disease Testing Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Point of Care Infectious Disease Testing Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Point of Care Infectious Disease Testing Market Size Forecast by Type
      13.6.1 HIV POC
      13.6.2 HBV POC
      13.6.3 Pneumonia or Streptococcus Associated Infections
      13.6.4 Respiratory Syncytial Virus (RSV) POC
      13.6.5 HPV POC
      13.6.6 Influenza POC
      13.6.7 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Point of Care Infectious Disease Testing Market Size Forecast by Applications
      13.10.1 Hospitals
      13.10.2 Clinics
      13.10.3 Home
      13.10.4 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Point of Care Infectious Disease Testing Market: Competitive Dashboard
   14.2 Global Point of Care Infectious Disease Testing Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Alere
      14.3.2 Thermo Fisher Scientific
      14.3.3 F. Hoffmann-La Roche
      14.3.4 Siemens Healthineers
      14.3.5 BD
      14.3.6 Chembio Diagnostics
      14.3.7 Trinity Biotech
      14.3.8 Cardinal Health
      14.3.9 Quest Diagnostics
      14.3.10 Bio-Rad Labs
      14.3.11 bioMérieux
      14.3.12 Sight Diagnostics
      14.3.13 Gene POC
      14.3.14 Trivitron Healthcare
      14.3.15 OJ-Bio
      14.3.16 Ortho-Clinical Diagnostics

Our Trusted Clients

Contact Us